BIRC5 and cancer: For an in vitro assessment of the self-renewal capacity of cancer stem cells, HT-29 cells were treated with the EpCAM aptamer-survivin siRNA chimera or negative control chimera, followed by further incubation in the presence or absence of 2 μM 5-FU for 5 days.